Rates of Congestion and CV Outcomes in Patients Hospitalized for Acute Heart Failure
Researchers examined if the rate of decongestion in acute heart failure is associated with cardiovascular outcomes and mortality.
Researchers examined if the rate of decongestion in acute heart failure is associated with cardiovascular outcomes and mortality.
Investigators examined in-hospital mortality in patients hospitalized with COVID-19 with new-onset atrial arrhythmias and history of atrial arrhythmias.
The phase 3 EMPEROR-Preserved trial included 5988 adult patients with heart failure with preserved ejection fraction, with and without diabetes.
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
Researchers assessed whether medications used for benign prostatic hyperplasia was associated with development of heart failure risk.
Investigators examined the effects of rivaroxaban (20 mg once daily) vs dose-adjusted warfarin in patients with atrial fibrillation and a bioprosthetic mitral valve.
Risk-standardized mortality rates for ischemic heart disease and heart failure vary considerably across Veterans Affairs Medical Centers.
Patients with resistant hypertension had a modest increase in risk of developing sleep apnea compared to those with nonresistant hypertension.